drugset / Trial / NCT05684289

A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)

NCT05684289

Phase 1 Completed 61 enrolled Bristol-Myers Squibb
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability, drug levels and drug effect of BMS-986278 in healthy adult participants and Japanese participants.

Timeline

Start
2023-01-03
Primary completion
2023-05-02
Completion
2023-05-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Admilparant Small molecule
Subject Sildenafil Unknown

Indications

No indication recorded.